Full Coverage
Novartis' gene therapy Zolgensma will cost $2.1 million
By Berkeley Lovelace, Angelica Peebles & Berkeley Lovelace Jr.
Novartis slaps $2M-plus price tag on newly approved gene therapy Zolgensma—and cost watchdogs approve
By Carly Helfand
This New Treatment Could Save the Lives of Babies. But It Costs $2.1 Million. (Published 2019)
By Katie Thomas
